Crescita Therapeutics' IPO

Crescita Therapeutics raised a round of funding on March 08, 2016. Investors include Public.

Crescita Therapeutics is a drug development company that owns topical products for treating medical conditions in dermatology and pain. The Company's licensed product is Pliaglis.…

Articles about Crescita Therapeutics' IPO: